Treatment of atrial fibrilation - a clear objectivewith a still obscure resolution
P. Neužil; M. Táborský; L. Šedivá; P. Niederle
Kardiologické oddělení Nemocnice Na Homolce, Praha, přednosta doc. MUDr. P. Niederle, DrSc.
Prakt. Lék. 2004; (6): 330-333
Atrial fibrilation is of the most frequent arrhythmias in our population and is on the increase.Its overall prevalence is 0.5%, and in the population of aver 65 years of age it is 5%, and in thoseover 75 years even 9%. Its occurrence in patients suffering cardiovascular affections leads toa twofold morbidity and mortality and is the most frequent cause of a cerebral vascular event.Unlike other cardial arrhythmias the treatment of atrial fibrilation has no uniform pattern,and an individual approach is necessary. As a basis of therapy in newly established cases ofatrial fibrilation pharmacological treatment namely with IC and group III anti-arrhythmicalsis preferred.The authors present a review of therapy under check-up of ventricular response, the options ofanticoagulation treatment as well as non-pharmacological treatment of atrial fibrilation.
atrial fibrilation - treatment - anti-arrhythmicals - beta-blockers - cathetrizingablation.
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP
General practitioner for children and adolescents
General practitioner for adults